DXPEMEDIUM SIGNALFINANCIAL10-K

DXPE demonstrated strong growth with total sales reaching $2.0 billion (up from $1.8 billion) and significantly improved cash position, though accompanied by substantial increases in debt and interest expense.

The company shows healthy operational momentum with 25.8% net income growth and expanding business scale, but investors should monitor the 82.4% spike in interest expense and 36.4% debt increase. The doubling of cash reserves suggests either recent financing activity or strong cash generation, providing financial flexibility but potentially indicating preparation for major investments or acquisitions.

Comparing 2026-02-26 vs 2025-03-10View on EDGAR →
FINANCIAL ANALYSIS

DXPE's financials reflect a growth company scaling operations, with total assets expanding 24.9% to $1.7B and current assets growing 37.5%, driven primarily by a dramatic 105% increase in cash to $303.8M. However, this growth came with increased leverage as total debt rose 36.4% to $330M, resulting in interest expense nearly doubling to $53.1M. Despite higher financing costs, strong operational performance drove net income up 25.8% to $88.7M and operating income up 21.7%, while increased capex of $40.3M and reduced share buybacks suggest the company is prioritizing growth investments over shareholder returns.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+104.8%
$148.3M$303.8M

Cash position surged 104.8% — strong cash generation or capital raise providing significant financial cushion.

Interest Expense
P&L
+82.4%
$29.1M$53.1M

Interest expense surged 82.4% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
+60.7%
$25.1M$40.3M

Capital expenditure jumped 60.7% — major investment cycle underway; assess returns on deployment.

Share Buybacks
Cash Flow
-41%
$29.0M$17.1M

Buyback activity reduced 41% — capital being redeployed elsewhere or cash conservation underway.

Current Assets
Balance Sheet
+37.5%
$661.9M$910.3M

Current assets grew 37.5% — improving short-term liquidity or inventory/receivables build.

Total Debt
Balance Sheet
+36.4%
$242.0M$330.0M

Debt increased 36.4% — substantial leverage increase; assess whether deployed for growth or covering losses.

Total Liabilities
Balance Sheet
+28.1%
$926.7M$1.2B

Liabilities increased 28.1% — monitor debt-to-equity ratio and interest coverage.

Net Income
P&L
+25.8%
$70.5M$88.7M

Net income grew 25.8% — bottom-line growth signals improving overall business health.

Total Assets
Balance Sheet
+24.9%
$1.3B$1.7B

Asset base grew 24.9% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+21.7%
$145.4M$176.9M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-10
ADDED
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 84 9A.
Sales, income from operations, total assets, and other financial information for our business segments are presented in Note 20 Segment Reporting to the Consolidated Financial Statements in Item 8.
Summary Sales and Income from Operations by Business Segment ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Our total sales have increased from $125 million in 1996 to $2.0 billion in 2025 through a combination of internal growth and business acquisitions.
SC sales/facility $ 8.2 $ 7.7 $ 7.5 $ 6.5 $ 5.4 $ 4.2 $ 5.3 $ 4.8 $ 3.9 $ 3.7 IPS sales $ 390 $ 309 $ 204 $ 199 $ 140 $ 188 $ 304 $ 292 $ 204 $ 187 IPS facilities 36 32 22 20 18 10 10 11 11 11 Avg.
IPS sales/facility $ 10.8 $ 9.7 $ 9.3 $ 9.9 $ 7.8 $ 18.8 $ 30.4 $ 26.5 $ 18.5 $ 17.0 SCS sales $ 253 $ 256 $ 260 $ 240 $ 158 $ 155 $ 201 $ 174 $ 161 $ 154 SCS customer sites 89 86 81 95 82 79 89 83 67 67 Avg.
+7 more — sign up free →
REMOVED
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 78 9A.
Sales, operating income, and other financial information for 2024, 2023 and 2022, and identifiable assets at the close of such years for our business segments are presented in Note 20 Segment Reporting to the Consolidated Financial Statements in Item 8.
Summary Sales and Operating Income by Business Segment ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Our total sales have increased from $125 million in 1996 to $1.8 billion in 2024 through a combination of internal growth and business acquisitions.
SC sales/facility $ 7.6 $ 7.5 $ 6.5 $ 5.4 $ 4.2 $ 5.3 $ 4.8 $ 3.9 $ 3.7 $ 4.6 IPS sales $ 323 $ 219 $ 199 $ 140 $ 188 $ 304 $ 292 $ 204 $ 187 $ 255 IPS facilities 32 22 20 18 10 10 11 11 11 12 Avg.
IPS sales/facility $ 10.1 $ 10.0 $ 9.9 $ 7.8 $ 18.8 $ 30.4 $ 26.5 $ 18.5 $ 17.0 $ 21.3 SCS sales $ 256 $ 260 $ 240 $ 158 $ 155 $ 201 $ 174 $ 161 $ 154 $ 166 SCS customer sites 86 81 95 82 79 89 83 67 67 69 Avg.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →